Article info
PDFReview
Subcutaneous levetiracetam for the management of seizures at the end of life
- Correspondence to Dr Anna Elizabeth Sutherland, Sue Ryder Hospice, Joyce Grove, Nettlebed, Henley-on-Thames RG9 5DF, UK; annasutherland{at}doctors.org.uk
Citation
Subcutaneous levetiracetam for the management of seizures at the end of life
Publication history
- Received October 17, 2016
- Revision received April 11, 2017
- Accepted May 20, 2017
- First published July 22, 2017.
Online issue publication
September 15, 2018
Article Versions
- Previous version (15 September 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.